Aimei Health Technology Co Ltd(AFJK) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 2 at 4:00 PM ET (Korea 11/3 06:00)
Full metrics table
| Index | - | P/E | 175.79 | EPS (ttm) | 0.07 | Insider Own | 64.96% | Shs Outstand | 3.2M | Perf Week | 1.15% |
| Market Cap | 0.04B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 1.1M | Perf Month | 0.74% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | - | Inst Own | 30.78% | Short Float | 0.2% | Perf Quarter | 1.08% |
| Income | 0.00B | P/S | - | EPS this Y | - | Inst Trans | - | Short Ratio | 0.12 | Perf Half Y | -71.95% |
| Sales | 0.00B | P/B | 4.83 | EPS next 5Y | - | ROA | 1.44% | Short Interest | 0.00M | Perf YTD | -80.94% |
| Book/sh | 2.53 | P/C | - | EPS past 3/5Y | 200.61% - | ROE | 1.66% | 52W High | -90.64% ($130.37) | Perf Year | 6.64% |
| Cash/sh | 0 | P/FCF | - | Sales past 3/5Y | - | ROIC | 5.15% | 52W Low | 80.74% ($6.75) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -69.33% | Gross Margin | - | Volatility(W/M) | 1.1% 1.06% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.31 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 0.01 | EPS Q/Q | -137.9% | Profit Margin | - | RSI (14) | 48.12 | Recom | - |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.01 | Sales Q/Q | - | SMA20 | -0.15% ($12.22) | Beta | 0.97 | Target Price | - |
| Payout | - | Debt/Eq | 0.28 | Earnings | - | SMA50 | 0.03% ($12.2) | Rel Volume | 0.18 | Prev Close | $12.2 |
| Employees | 2 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -60.6% ($30.96) | Avg Volume(3M) | 0.02M | Price | $12.2 |
| IPO | 2024/1/22 | Option/Short | No/Yes | Trades | 62 | Volume | 3,392 | Change | - |
This is a SPAC (Special Purpose Acquisition Company) pursuing a merger with United Hydrogen Group, a Chinese hydrogen solutions company. It has repeatedly extended its merger deadline to keep the deal moving forward, and the stock exhibits very high price volatility.
Over the past 1 year, on the lower side
91% below its 1-year high.
Traded less than usual. That is 18% of its average volume.
Company yardsticks do not fit here, so profitability, valuation and earnings are left out. The other verdicts still apply.
Long-term returns are roughly flat
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership looks stable
Institutions hold 30.8%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
SPCZ RiverNorth Enhanced Pre-Merger SPAC ETF <0.01% 
RNMN RiverNorth Market Neutral ETF <0.01% It ranks #1372 of 1436 in the industry
Based on market cap of $39M.
NCTY#1367 The9 Limited ADR $40M PER - AFJK#1372 Aimei Health Technology Co Ltd $39M PER 175.8 
AVAT#1373 Avalanche Treasury Corp $38M PER - 
MLCI#1374 Mount Logan Capital Inc $38M PER - 
VRM#1376 Vroom Inc $37M PER - 
FAQ
What kind of company is AFJK?
AFJK belongs to the Financial sector and operates in the Shell Companies industry.
What is the market cap of AFJK?
The market cap of AFJK is approximately $39M, ranking 4,966 within its sector.
What is the P/E ratio of AFJK?
AFJK has a P/E ratio of approximately 175.8x, which can be used to assess its valuation relative to the Financial sector average.
What is the 52-week high and low for AFJK?
AFJK has recorded a 52-week high of $130.37 and a low of $6.75.
